Mar 1, 2022Leadership & CorporateMablink Bioscience announces appointment of its Chief Development Officer
Oct 21, 2021Financial & BusinessLicensing Agreement with Emergence Therapeutics to Develop Antibody Drug Conjugate
Apr 27, 2021Financial & BusinessMablink, the next-generation ADC company, raises €4 Million from a syndicate of private investors
Nov 5, 2020Science & MedicineMablink is invited to present at the 12th annual PEGS Europe Virtual summit (November 9-12, 2020)